Search Results - "Sheppard, Michael C"

Refine Results
  1. 1

    Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study by Parle, James V, Maisonneuve, Patrick, Sheppard, Michael C, Boyle, Peter, Franklyn, Jayne A

    Published in The Lancet (British edition) (15-09-2001)
    “…Low serum thyrotropin, in combination with normal concentrations of circulating thyroid hormones, is common, especially in elderly people and in individuals…”
    Get full text
    Journal Article
  2. 2

    Primary medical therapy for acromegaly by Sheppard, Michael C.

    Published in Clinical endocrinology (Oxford) (01-04-2003)
    “…Summary There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sustaining fossil fuel use in a carbon-constrained world by rapid commercialization of carbon capture and sequestration by Sheppard, Michael C, Socolow, Robert H

    Published in AIChE journal (01-12-2007)
    “…Various aspects related to sustaining fossil fuel use in a carbon-constrained world by rapid commercialization of carbon capture and sequestration (CCS), are…”
    Get full text
    Journal Article
  5. 5

    Mortality in Patients with Pituitary Disease by Sherlock, Mark, Ayuk, John, Tomlinson, Jeremy W, Toogood, Andrew A, Aragon-Alonso, Aurora, Sheppard, Michael C, Bates, Andrew S, Stewart, Paul M

    Published in Endocrine reviews (01-06-2010)
    “…Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and…”
    Get full text
    Journal Article
  6. 6

    Long-Term Safety and Efficacy of Depot Long-Acting Somatostatin Analogs for the Treatment of Acromegaly by Ayuk, John, Stewart, Susan E., Stewart, Paul M., Sheppard, Michael C.

    “…Depot somatostatin analogs are now increasingly being prescribed as adjuvant and primary therapy for the treatment of acromegaly. Previous studies have shown…”
    Get full text
    Journal Article
  7. 7

    Cardiac Dysrhythmias and Thyroid Dysfunction - The Hidden Menace? by Osman, Faizel, Gammage, Michael D., Sheppard, Michael C., Franklyn, Jayne A.

    “…Thyrotoxicosis is often perceived as a reversible disorder without long-term consequences, perhaps because of the availability of effective treatments, but…”
    Get full text
    Journal Article
  8. 8

    Medical therapy in acromegaly by Sherlock, Mark, Woods, Conor, Sheppard, Michael C.

    Published in Nature reviews. Endocrinology (01-05-2011)
    “…Acromegaly is a rare condition, which is associated with increased morbidity and mortality, both of which can be reduced with appropriate therapy. This Review…”
    Get full text
    Journal Article
  9. 9

    Successful treatment of amiodarone-induced thyrotoxicosis by OSMAN, Faizel, FRANKLYN, Jayne A, SHEPPARD, Michael C, GAMMAGE, Michael D

    Published in Circulation (New York, N.Y.) (19-03-2002)
    “…Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data. We examined whether continuing…”
    Get full text
    Journal Article
  10. 10

    Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment by Osman, Faizel, Franklyn, Jayne A., Daykin, Jacqueline, Chowdhary, Saqib, Holder, Roger L., Sheppard, Michael C., Gammage, Michael D.

    Published in The American journal of cardiology (15-08-2004)
    “…Patients with subclinical and treated overt hyperthyroidism have an excess vascular mortality rate. Several symptoms and signs in overt hyperthyroidism suggest…”
    Get full text
    Journal Article
  11. 11

    Thyroid Function and Mortality in Patients Treated for Hyperthyroidism by Franklyn, Jayne A, Sheppard, Michael C, Maisonneuve, Patrick

    “…CONTEXT Hyperthyroidism has been reported to cause excess all-cause and circulatory mortality. Whether this can be reversed is unknown, as is the influence of…”
    Get full text
    Journal Article
  12. 12

    Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy : A matched case-control study by OSMAN, Faizel, FRANKLYN, Jayne A, HOLDER, Roger L, SHEPPARD, Michael C, GAMMAGE, Michael D

    “…This study sought to prospectively evaluate the prevalence of cardiovascular abnormalities in patients with overt hyperthyroidism before and after antithyroid…”
    Get full text
    Journal Article
  13. 13

    Does acromegaly enhance mortality? by Ayuk, John, Sheppard, Michael C.

    Published in Reviews in endocrine & metabolic disorders (01-03-2008)
    “…The increased mortality associated with acromegaly was first demonstrated in early epidemiological studies. Since the seminal paper by Wright et al. in 1970,…”
    Get full text
    Journal Article
  14. 14

    A Paradigm Shift in the Monitoring of Patients With Acromegaly: Last Available Growth Hormone May Overestimate Risk by Sherlock, Mark, Reulen, Raoul C, Aragon-Alonso, Aurora, Ayuk, John, Clayton, Richard N, Sheppard, Michael C, Hawkins, Michael M, Bates, Andrew S, Stewart, Paul M

    “…Context: Acromegaly is associated with reduced life expectancy, which has been reported to be normalized if treatment is successful in controlling GH/IGF-I…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Fibroblast Growth Factors 1 and 2 and Fibroblast Growth Factor Receptor 1 Are Elevated in Thyroid Hyperplasia by Thompson, Stuart D, Franklyn, Jayne A, Watkinson, John C, Verhaeg, Julie M, Sheppard, Michael C, Eggo, Margaret C

    “…We have previously reported increased expression of fibroblast growth factor (FGF-1 and FGF-2) in benign and malignant human thyroid neoplasia. To determine…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Radioiodine treatment of hyperthyroidism-prognostic factors for outcome by ALLAHABADIA, Amit, DAYKIN, Jacquie, SHEPPARD, Michael C, GOUGH, Stephen C. L, FRANKLYN, Jayne A

    “…There is little consensus regarding the most appropriate dose regimen for radioiodine (131I) in the treatment of hyperthyroidism. We audited 813 consecutive…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace? by Osman, Faizel, Gammage, Michael D, Sheppard, Michael C, Franklyn, Jayne A

    “…Thyrotoxicosis is often perceived as a reversible disorder without long-term consequences, perhaps because of the availability of effective treatments, but…”
    Get full text
    Journal Article